FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Product Submission Certifications Information Collection

Federal Register notice: FDA sends to OMB an information collection extension for Certification To Accompany Drug, Biological Product, and Device Appl...

Federal Register

OMB Approves 6 FDA Info Collections

Federal Register notice: FDA posts a list of six information collections that have been approved by the Office of Management and Budget.

Marketing

FDA Ad/Promotion Enforcement Continuing on Same Track: Analysis

Two attorneys say that despite fewer Office of Prescription Drug Promotion enforcement letters in 2020 they expect advertising and promotion enforceme...

Medical Devices

FDA Approves a World First Bone Implant

FDA gives humanitarian device approval to the Additive Orthopaedics patient-specific talus spacer 3D-printed bone implant, a world first.

Medical Devices

Make Changes to Electromagnetic Compatibility Testing: AdvaMed

Two stakeholders comment on an FDA draft guidance on electromagnetic compatibility testing of medical devices.

Federal Register

Expedited Programs for Drugs/Biologics Info Collection

Federal Register notice: FDA sends to OMB an information collection extension for Expedited Programs for Serious Conditions Drugs and Biologics.

Medical Devices

Medtronic Expanded MRI Labeling for InterStim Devices

FDA approves expanded MRI labeling for Medtronics InterStim II and InterStim Micro sacral neuromodulation systems that use SureScan MRI leads.

Human Drugs

2 Padcev sBLAs Submitted to FDA

Astellas and Seagen file sBLAs with FDA to change Padcev to regular approval and expand its indication.

Federal Register

Comments Sought on WHO Drug Scheduling Recommendations

Federal Register notice: FDA seeks comments on recommendations by the World Health Organization to impose international manufacturing and distributing...

Biologics

FDA Facilitating Efforts to Coordinate Regenerative Medicine Therapy Standards

FDA updates its efforts to coordinate the development of standards for regenerative medicine therapies as required by the 21st Century Cures Act.